Skip to content
Home/Companies/Biotech/Dillico
Dillico

Dillico

Biotech·France·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Dillico?

Dillico is a French Biotech company, currently owned by ANGELOR since 2024.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
ANGELOR
Investor
ANGELOR
Angelor · 2014 · VC

Key facts

HQFrance
SectorBiotech
Websitedillico.com

More from Angelor

Other portfolio companies in the same fund.

Axoltis Pharma
Axoltis Pharma
Active
BiotechFrance· 2024
Brenus Pharma
Brenus Pharma
Active
BiotechFrance· 2024
Hawk Cell
Hawk Cell
Active
BiotechFrance· 2024
Pixee Medical
Active
MedTechFrance· 2024
Standing Ovation
Active
BiotechFrance· 2024
Wise Integration
Wise Integration
Active
Deep TechFrance· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Dillico?

Dillico is currently owned by ANGELOR, through Angelor, since 2024.

When did ANGELOR acquire Dillico?

ANGELOR acquired Dillico in 2024.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue